Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cationic amino acid transporter 4 (CAT4), encoded by the SLC7A4 gene, is a member of the solute carrier family 7 that mediates the transport of cationic amino acids such as lysine, arginine, and ornithine across plasma membranes[1][3][7]. While the functional and structural profile is consistent with the SLC7 (solute carrier) transporter superfamily, its exact biological significance and transport activity in humans remain less fully characterized than other SLC7 family members. There are no approved drugs directly targeting SLC7A4 or well-established roles in major disease areas according to currently available resources[3][7].
Not established for drugs directly targeting this transporter; for the SLC7 family in general: inhibition or modulation of amino acid transport[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cationic amino acid transporter 4 (CAT4).